Fig. 9From: Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validationThe simulation results of NFATc1-BCA, ERK-BCA, JNK-BCA and c-FOS-BCA receptor-ligand complexesBack to article page